Notice: This company has been marked as potentially delisted and may not be actively trading. (BIOA) (BIOA) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOwnershipTrendsBuy This Stock Get the Latest News and Ratings for BIOA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for (BIOA) and its competitors. Enter your email to sign up for newsletter Sign Up BIOA Analyst Ratings Over TimeTypeCurrent Forecast3/31/24 to 3/31/251 Month Ago3/1/24 to 3/1/253 Months Ago1/1/24 to 12/31/241 Year Ago4/1/23 to 3/31/24Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s) N/A Buy0 Buy rating(s)0 Buy rating(s)0 Buy rating(s) N/A Hold3 Hold rating(s)3 Hold rating(s)2 Hold rating(s) N/A Sell1 Sell rating(s)1 Sell rating(s)1 Sell rating(s) N/A Consensus Price Target$5.67$6.33$6.33N/AForecasted Upside50.75% Upside36.94% Upside11.90% UpsideN/AConsensus RatingReduceReduceReduceN/A Remove Ads BIOA Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History BIOA Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table (BIOA) Stock vs. The CompetitionType(BIOA)Medical CompaniesS&P 500Consensus Rating Score 1.75 2.82 2.54Consensus RatingReduceModerate BuyModerate BuyPredicted Upside50.75% Upside19,274.41% Upside19.01% UpsideNews Sentiment RatingNeutral NewsSee Recent BIOA NewsPositive NewsPositive News Remove Ads Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails3/24/2025Citigroup3 of 5 starsS. SemenkowSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower TargetNeutral ➝ Neutral$7.00 ➝ $5.00+12.36%3/21/2025William Blair1 of 5 starsA. HsiehSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Perform3/7/2025Morgan Stanley3 of 5 starsJeffrey HungSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingUnderweight$5.00+10.50%12/9/2024Jefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating DowngradeBuy ➝ Hold$42.00 ➝ $7.00-65.16%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 06:21 PM ET. BIOA Forecast - Frequently Asked Questions What is (BIOA)'s forecast for 2025? According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for (BIOA) is $5.67, with a high forecast of $7.00 and a low forecast of $5.00. Should I buy or sell (BIOA) stock right now? 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for (BIOA) in the last twelve months. There is currently 1 sell rating and 3 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "reduce" BIOA shares. Does (BIOA)'s stock price have much upside? According to analysts, (BIOA)'s stock has a predicted upside of 50.75% based on their 12-month stock forecasts. What analysts cover (BIOA)? (BIOA) has been rated by research analysts at Citigroup, Morgan Stanley, and William Blair in the past 90 days. Do Wall Street analysts like (BIOA) more than its competitors? Analysts like (BIOA) less than other "medical" companies. The consensus rating for (BIOA) is Reduce while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how BIOA compares to other companies. Stock Forecasts and Research Tools Related Companies ABUS Stock Forecast BCYC Stock Forecast DNTH Stock Forecast KURA Stock Forecast KALV Stock Forecast CAPR Stock Forecast PHAR Stock Forecast ARVN Stock Forecast ANAB Stock Forecast MRVI Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NYSE:BIOA) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (BIOA) Please log in to your account or sign up in order to add this asset to your watchlist. Share (BIOA) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BIOA Stock Free BIOA Stock Alerts